Notice Number: NOT-HL-19-743
Key Dates
Release Date: January 15, 2020
PAR-19-342
Issued by
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating, effective immediately, in PAR-19-342, "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)."
The following sections of PAR-19-342 have been updated to reflect the participation of NHLBI in this Funding Opportunity Announcement (FOA). Additions are italicized.
Part 1. Overview Information
Components of Participating Organizations
National Institute of General Medical Sciences (NIGMS)
National Institute of Mental Health (NIMH)
National Heart, Lung and Blood Institute (NHLBI)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.859, 93.242, 93.233, 93.837, 93.838, 93.839, 93.840
Part 2. Full Text of Announcement
Program Considerations
NIH intends to fund applications that propose feasible and effective research education activities that will enhance diversity in the biomedical research workforce. Applicants are expected to identify objectives (i.e., specific, measurable, and obtainable outcomes the program intends to achieve) and to develop plans to implement evidence-based skills development and mentoring activities that are grounded in the literature and from evaluations of existing relevant programs. Program objectives must align with the overarching goal of the MOSAIC initiative to enhance diversity in the professoriate at research-intensive institutions. Funded programs are expected to provide evidence of accomplishing the objectives in progress reports and upon renewal, to make outcomes publicly available, and to disseminate successful mentoring and skills development practices to the broader community.
The primary participants in MOSAIC research education activities will be scholars selected through the MOSAIC K99/R00 program. UE5 awardees are not responsible for the selection of the MOSAIC K99/R00 scholars - this will be managed by an NIH competitive peer review process as described in the MOSAIC K99/R00 FOA. The funded UE5 awardees will develop cohorts of MOSAIC K99/R00 scholars assigned by NIH staff (see below in the Cooperative Agreement section). Funded UE5 organizations are expected to provide professional development and enhance the professional networks of cohorts of MOSAIC K99/R00 scholars conducting research in areas specific to the mission(s) of participating NIH institute(s) and center(s). The specific NIH institute and center scientific areas supported through this FOA include:
NIGMS: NIGMS supports basic research that increases our understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention. NIGMS' research mission is aimed at understanding the principles, mechanisms, and processes that underlie living systems. It also supports research in specific clinical areas that affect multiple organs, particularly those related to injury and critical illness: sepsis, trauma, burn, wound healing, anesthesiology, and clinical pharmacology. For more information see https://www.nigms.nih.gov/about/overview/pages/default.aspx
NHLBI: NHLBI provides global leadership for a research, research training, and education program to promote the prevention and treatment of heart, lung, blood, and sleep diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives. The NHLBI encourages research designed to answer the breadth of scientific questions related to heart, lung, blood, and/or sleep diseases, disorders, and phenotypes. The NHLBI seeks applications that will address questions relevant to the NHLBI mission, address gaps in the NHLBI's portfolio, and should align with the NHLBI's Strategic Vision. NHLBI's strategic priorities emphasize the continuum of research from basic molecular biology research to implementation science related to heart, lung, blood diseases and sleep disorders (e.g. hemoglobinopathies and other non-malignant blood diseases; thrombotic and hemostasis disorders; cardiovascular diseases; hypertension prevention and control; asthma; chronic obstructive pulmonary disease (COPD), sleep apnea; and other cardiopulmonary diseases and conditions), self-management of symptoms and disease conditions, and prevention of these diseases and disorders in various populations. The NHLBI also has significant interests in implementation science research for the prevention, control, and treatment of heart, lung, blood diseases and sleep disorders, particularly research that addresses the development of interventions or strategies that address the translation of proven effective evidence-based interventions into clinical, community, and/or other real world settings; addresses impediments to uptake, scale up, and sustainability of evidence-based interventions in various contexts; examines disparities in disease burden and ways to mitigate these disparities; and/or models possible treatment paradigms. Please refer to the NHLBI website for more details on the research priorities of the NHLBI.
Inquiries
Please direct all inquiries to:
Scientific/Research Contact(s)
Jane D. Scott, ScD, MSN, FAHA
Division of Cardiovascular Sciences
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0535
Email: [email protected]
Sharon M. Smith, PhD
Division of Blood Diseases and Disorders
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0050
Email: [email protected]
Roya Kalantari, PhD
Division of Lung Diseases
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-480-1989
Email: [email protected]
Melissa Green Parker, PhD
Center for Translation Research and Implementation Science
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-496-1051
Email: [email protected]
Financial/Grants Management Contact(s)
Benjamin Sakovich
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0166
Email: [email protected]
and Human Services (HHS)
